RIGL - Rigel Pharmaceuticals Incorporated

$8.87 -0.07 | -0.78%
Today's Range: 8.75 - 9.13
RIGL Avg. Daily Volume: 823,000
12/10/09 - 4:00 PM ET
TRADE NOW
Company Income Statement
Dec 2008 Dec 2007 Dec 2006 Dec 2005
Sales 0.00 12.60M 33.47M 16.53M
Cost of Sales -1.42M -1.34M -1.42M -1.18M
Gross Operating Profit 1.42M 13.94M 34.89M 17.71M
Selling, General, and Administrative Expenses 27.04M 21.76M 19.55M 12.41M
Research & Development 109.67M 70.36M 56.97M 52.04M
Operating Income before D & A (EBITDA) -135.29M -78.18M -41.63M -46.74M
Depreciation & Amortization 1.42M 1.34M 1.42M 1.18M
Interest Income 4.44M 5.48M 5.70M 2.94M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -132.28M -74.05M -37.35M -44.98M
Interest Expense 160.00K 221.00K 290.00K 276.00K
Pre-Tax Income -132.44M -74.27M -37.64M -45.26M
Income Taxes -89.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -132.35M -74.27M -37.64M -45.26M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -132.35M -74.27M -37.64M -45.26M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -132.35M -74.27M -37.64M -45.26M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -132.35M -74.27M -37.64M -45.26M
Preferred Dividends
Net Income Available To Common -132.35M -74.27M -37.64M -45.26M
Basic EPS from Continuing Ops. -3.67 -2.57 -1.51 -2.07
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -3.67 -2.57 -1.51 -2.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -3.67 -2.57 -1.51 -2.07
Basic Normalized Net Income/Share -3.67 -2.57 -1.51 -2.07
EPS fr Continuing Ops. -3.67 -2.57 -1.51 -2.07
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -3.67 -2.57 -1.51 -2.07
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -3.67 -2.57 -1.51 -2.07
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -3.67 -2.57 -1.51 -2.07
Dividends Paid per Share 0.00 0.00 0.00 0.00
Latest RIGL Headlines
More Financial News for RIGL
Partner Headlines

Brokerage Partners

TheStreet Premium Services

All Services